| | Experience
| | Jill A. Myers, Ph.D. has more than 20 years experience in the biotechnology industry. Dr. Myers has been consulting since 2005. Her clients range from virtual companies to established firms with commercial products. She has assisted clients in a variety of areas of biotherapeutics process development and manufacturing. The work has included both operational and strategic projects.
Before founding BioPro Consulting, Inc., Dr, Myers was Senior Director, Process Sciences and Production at Applied Molecular Evolution (AME), where she built the Process Sciences and Production function from scratch. This involved hiring a department (Cell Culture, Purification, Analytical, Formulation and Production groups) setting up laboratories, implementing infrastructure, design and construction of a GMP facility, developing a process for a biotherapeutic and producing material successfully used in human clinical trials.
After AME was acquired by Eli Lilly, Dr. Myers continued at the subsidiary with expanded responsibilities including coordination with Lilly colleagues on integration, defining the role of AME Development within the Lilly organization and scientific and strategic input into Lilly Biotherapeutics Development.
Before moving to AME, Dr. Myers was a Program Executive at Biogen with responsibility for managing a cross functional team for an early phase biotherapeutic. Before that she ran the Process Biochemistry group which was responsible for the purification process development of all clinical and commercial biotherapeutics, with major contributions to AVONEX® and AMEVIVE®, as well as many early phase programs.
Dr. Myers has also held bioprocess development positions at Repligen and Abbott Laboratories. She received her Ph.D. in Biochemistry from UCLA and did a post doctoral fellowship at Harvard Medical School. She is a member of the Board of the Recovery of Biological Products Conference Series, and has served on a variety of industry committees, IBC Scientific Advisory Boards, Southern California Validation Group, MIT Industrial Advisory Board and the PDA Biotechnology Cleaning Validation Committee. She has lectured in biomanufacturing at UCSD Extension and is the Group Leader for the Biotechnology Interest Group of the PDA.
Dr. Myers' technical expertise includes process development, production, downstream processing, technology transfer, working with Contract Manufacturing Organizations (CMOs) and more. Additionally, she has technical regulatory expertise with the Chemistry, Manufacturing and Controls (CMC) sections of INDs and BLAs, pre- and post-approval inspections, post-approval submissions, viral safety strategies. |  |
| |
|
 |
|
